{"nct_id":"NCT00526045","title":"Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients","status":"COMPLETED","status_verified_date":"2013-05","start_date":"2007-07","start_date_type":null,"primary_completion_date":"2012-04","primary_completion_date_type":"ACTUAL","completion_date":"2012-04","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}